Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Dec;233(23-24):3869-3879.
doi: 10.1007/s00213-016-4417-4. Epub 2016 Sep 22.

Opioid-receptor antagonism increases pain and decreases pleasure in obese and non-obese individuals

Rebecca C Price  1   2 , Nicolas V Christou  3 , Steven B Backman  4 , Laura Stone  2   5 , Petra Schweinhardt  6   7   8
Affiliations

Opioid-receptor antagonism increases pain and decreases pleasure in obese and non-obese individuals

Rebecca C Price et al. Psychopharmacology (Berl). 2016 Dec.

Abstract

Rationale: Endogenous opioids inhibit nociceptive processing and promote the experience of pleasure. It has been proposed that pain and pleasure lie at opposite ends of an affective spectrum, but the relationship between pain and pleasure and the role of opioids in mediating this relationship has not been tested.

Objectives: Here, we used obese individuals as a model of a dysfunctional opioid system to assess the role of the endogenous opioid peptide, beta-endorphin, on pain and pleasure sensitivity.

Methods: Obese (10M/10F) and age- and gender-matched non-obese (10M/10F) controls were included in the study. Pain sensitivity using threshold, tolerance, and subjective rating assessments and perceived sweet pleasantness using sucrose solutions were assessed in two testing sessions with placebo or the opioid antagonist, naltrexone (0.7 mg/kg body weight). Beta-endorphin levels were assessed in both sessions.

Results and conclusions: Despite having higher levels of baseline beta-endorphin and altered beta-endorphin-reactivity to naltrexone, obese individuals reported a similar increase in pain and decrease in pleasantness following naltrexone compared to non-obese individuals. Beta-endorphin levels did not correlate with pain or pleasantness in either group, but naltrexone-induced changes in pain and pleasantness were mildly correlated. Moreover, naltrexone-induced changes in pain were related to depression scores, while naltrexone-induced changes in sweet pleasantness were related to anxiety scores, indicating that pain and pleasantness are related, but influenced by different processes.

Keywords: Anxiety; Beta-endorphin; Depression; Naltrexone; Obesity; Opioid.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Psychiatry Res. 1983 Feb;8(2):119-25 - PubMed
    1. J Pharmacol Exp Ther. 1995 Dec;275(3):1293-9 - PubMed
    1. Acta Physiol Pol. 1988 May-Jun;39(3):183-7 - PubMed
    1. Cereb Cortex. 2003 Oct;13(10):1064-71 - PubMed
    1. Pediatr Res. 1995 Sep;38(3):332-5 - PubMed

LinkOut - more resources

-